Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$39.27 - $72.94 $144,984 - $269,294
-3,692 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$31.29 - $56.64 $115,522 - $209,114
3,692 New
3,692 $209,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $198M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Draper Asset Management, LLC Portfolio

Follow Draper Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Draper Asset Management, LLC with notifications on news.